Portfolio company
Anaconda Biomed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This medical technology company develops self-expanding funnel catheters for neurovascular mechanical thrombectomy procedures, serving hospitals and clinics treating patients with acute ischemic stroke.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biomedical Solutions
This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.
Julier Medical
This company develops an expandable endovascular catheter platform and mechanical thrombectomy devices for clinicians to treat patients experiencing acute ischemic strokes.
RapidPulse
This medical technology company develops a cyclic aspiration system for removing blood clots in patients suffering from acute ischaemic stroke.
Artiria Medical
The company develops deflectable guidewires for neurovascular procedures to help surgeons navigate complex brain arteries during stroke and aneurysm treatments.
PULSED ASPIRATION SYSTEM
This company develops a pulsed aspiration system for medical professionals to remove blood clots in patients with acute ischemic stroke.
Navigantis
This company develops an interventional robotic platform for neurovascular procedures to assist physicians in treating conditions such as acute ischemic stroke.
Acandis
This company manufactures neurovascular medical devices and stents for healthcare professionals to treat patients with haemorrhagic and ischaemic strokes.
Imperative Care
This company develops thrombectomy systems and digital health tools to treat patients suffering from strokes and other vascular diseases.
